Production optimization and characterization of anticancer enzyme L-Asparaginase from Bacillus Sp. using Moringa Oleifera Seeds by Batool, T. et al.
364 
Paper ID: A332 
Production Optimization and Characterization of Anticancer Enzyme L-Asparaginase From 
Bacillus Sp. Using Moringa Oleifera Seeds 
T. Batool 1, 2* E. A. Makky, 2 M. Khan, 1, 2 M.M. Yusoff 2 
1 Department of Biotechnology, Women University of Azad Jammu & Kashmir, Bagh, 12500, 
Pakistan,  2 Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 
Gambang, Pahang, Malaysia. 
3 Centre for Human Genetics, Hazara University Mansehra, 21120 Mansehra, Pakistan. 
Corresponding author: batool_hej@yahoo.com 
EXTENDED ABSTRACT 
L-Asparaginase (L-asparagine amino hydrolase 3.5.1.1) constitutes one of the most 
biotechnologically and bio medically important group of therapeutic enzymes accounting for about 
40% of the total worldwide enzyme sales [1, 2]. During current research L-asparaginase, was 
produced from Bacillus sp. Cultural parameters affecting the production of L-asparaginase were 
optimized [3]. Maximal yields of L-asparaginase were recorded from 5-day-old culture grown in 
nutrient broth in presence of Moringa Oleifera seeds as substrate with initial pH 7.0 at temperature 
37◦C [4, 5]. Ammonium chloride (1%) and galactose (1%) served as good nitrogen and carbon 
sources for L-asparaginase production, respectively. Na+and K+ slightly enhanced the productivity 
of L-asparaginase [6]. The in vitro antioxidant and antitumor activity of partially purified L-
asparaginase enzyme was also studied [7]. The enzyme showed a good scavenging activity against 
DPPH with IC50 value of 81.645µg/mL [8].  
To determine anticancer activity, different concentration of partially purified L-asparaginase was 
tested on heLa cell line by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay [9, 10]. The enzyme showed a significant anti-proliferative activity and a dose dependent effect 
was observed. The cytotoxicity assay was employed to determine the cytotoxic effects of partially 
purified enzyme from A9 bacteria on HeLa cell lines. The cell lines were exposed to varying 
concentration of 100, 50, 25, 12.5, 6.25 and 3.125 µg/mL of test samples for 24 hours. Percentage of 
cell viability was calculated. It can be observed from figure 1 that all samples exhibited dose-
dependent inhibition towards the cell lines used. The percentage of cell viability decreases as the 
samples concentration increase. L-asparaginase reduced the viability of the cancer cells. At low 
concentration of 3.125 µg/mL the viability of tumour cells reduced to 89.987% (cell death 10.013%). 
The dead cells reached to 66.255 % at 100 µg/mL. The IC50 value was found to be 69.826 µg/mL. 
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Fig. 1: Cytotoxic effect of A9 L-asparaginase on HeLa cancer cell line at 24 h incubation 
Moringa olefiera seeds were used as natural substrate to produce anticancer enzyme L-asparaginase 
enzyme by fermentation using Bacillus sp. Seven parameters carbon, nitrogen, pH, temperature, 
substrate concentration, inoculum volume and incubation period were optimized for enhanced 
production of L-asparaginase. Effect of various effectors and antioxidant properties of partially 
purified enzyme were studied.  Furthermore, L-asparaginase also exhibited a cytotoxic effect against 
cancer cell line in vitro. In conclusion, high catalytic activity of the enzyme over a wide range of pH 
and temperature and its considerable stability makes it highly favorable for use as potent anticancer 
agent.  
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